Alison Gilmour BSc (Hons) MRPharmS Pharmacist Independent Prescriber
GPhC 2050969
BEAUTIFEYE BY FILLMED
'The Eye Treatment' - this revitalising treatment refreshes tired eyes, diminishes fine lines and wrinkles and reduces dark circles to restore radiance to the eye contour area.
What is Beautif-Eye?
The unique Beautif-Eye treatment protocol is specifically developed to target fine and fragile skin around the eyes.
The unique mesotherapy solution, NCTF® 135HA is delivered using the NANOSOFT™ microneedle device.
The innovative needle design comprises three tiny 0.6mm long microneedles which minimise the risk of bruising when used on the delicate areas around the eyes.
This also enables a nearly-painless, shallow and consistent delivery of product.
What is NCFT135HA?
NCTF® 135HA (New Cellular Treatment Factor) is a unique, polyrevitalising solution containing 60 active ingredients including hyaluronic acid, vitamins and peptides.
NCTF improves skin quality and texture as it provides the dermis with the essential ingredients it needs to produce collagen and elastin.
By maximising hydration, it reduces the appearance of fine lines and wrinkles and the restores skin brightness, deeply nourishes the skin and increasing skin thickness.
What to expect on the day
The treatment takes around 45 minutes and comprises 3 steps:
A light Chemical Peel designed to target pigmentation and to lighten and brighten the skin.
Micro-injections of NCTF® 135HA skin booster to the problem areas around the eyes
Skin Perfusion Eye Recovery Mask is applied, targeting signs of ageing, dark circles, puffiness, wrinkles and drooping eyelids.
After your treatment you will leave the clinic with small 'blebs' under the skin, which may be visible for up to 48 hours as the product disperses under the skin. Swelling is also to be expected and there is a possibly of bruising at the injection point too.
Recommended Treatment Protocol
Initially 3 sessions are required, 2 weeks apart. Thereafter, we recommend one session every 5 or 6 months to maintain the results.